MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-20 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Muscle Weakness (1967); Muscular Rigidity (1968); Overdose (1988); Weakness (2145); Therapeutic Response, Decreased (2271); Underdose (2542)
|
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a foreign healthcare provider (hcp) via a manufacturer representative regarding a patient who was receiving lioresal (baclofen) (500mcg/ml at 440mcg/ml day) via an implantable pump for unknown indications for use.It was reported that the patient experienced symptoms of deprivation (underdose), including more rigidity, during the afternoon and weakness during the morning. this was also described as "sometimes deprivation and sometimes excess of baclofen." the exact dates were reportedly unknown.They tried increasing the dose a few times, but there was no effect.The surgeons decided to replace the pump and the pump segment of the catheter.No dye study or roller study was performed prior to the replacement.It was noted that the spinal segment of the catheter was checked and was in good condition.The reservoir of the pump was also checked and coincided with the tablet.In addition, they had not observed any discrepancies in previous refills.It was stated that probably the pump was okay, but for safety they decided to replace.It was indicated that there was no data available related to any environmental/external/patient factors that may have led or contributed to the issue.The explant took place on (b)(6) 2020 and it was noted the product would be returned.At the time of the initial report on (b)(6) 2020 it was unknown if the issue was resolved, but additional information later received on 2020-nov-11 indicated that the patient was now responding well to treatment and it seemed the device replacement resolved the event.No further complications were reported.
|
|
Manufacturer Narrative
|
H3: the returned device was subjected to a series of standard tests that include but is not limited to visual inspection, alarm output, motor function, and dispense testing.The returned device passed all testing in the laboratory and no anomalies were identified.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|